Bellinzona, Switzerland

Dora Pinto

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2021-2022

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Dora Pinto

Introduction

Dora Pinto is a notable inventor based in Bellinzona, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies against SARS-CoV-2. Her work is crucial in the ongoing fight against COVID-19.

Latest Patents

Dora Pinto holds 2 patents related to her innovative research. Her latest patents focus on antibodies and antigen-binding fragments that can effectively bind to a SARS-CoV-2 antigen. These antibodies are capable of neutralizing SARS-CoV-2 infections. Additionally, her patents include polynucleotides that encode these antibodies, as well as vectors and host cells that comprise these polynucleotides. The pharmaceutical compositions and methods she has developed are aimed at treating or diagnosing SARS-CoV-2 infections.

Career Highlights

Dora Pinto is currently associated with Vir Biotechnology, Inc., where she continues her groundbreaking research. Her work has positioned her as a key player in the biotechnology sector, particularly in the context of infectious diseases.

Collaborations

Dora collaborates with esteemed colleagues such as Davide Corti and Katja Fink. Their combined expertise enhances the research efforts at Vir Biotechnology, Inc., leading to innovative solutions in the fight against viral infections.

Conclusion

Dora Pinto's contributions to biotechnology, particularly in developing antibodies against SARS-CoV-2, highlight her role as an influential inventor. Her work not only advances scientific knowledge but also has the potential to save lives.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…